Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

Testing the Safety and Acceptability of Using a Rewetting Drop with Contact Lenses

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ametropia Eye Diseases Refractive Errors

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

San Diego, California, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adapted contact lens wearer

Exclusion criteria

Monovision lens wearer, ocular or systemic disease, pregnant or planning to become pregnant

Treatment and study plan

Carboxymethylcellulose sodium and Glycerin

Device

Eye drops used at least 4 times per day, 1-2 drops in each eye while wearing contact lenses.

Other names: Optive™

Carboxymethylcellulose sodium

Device

Eye drops used at least 4 times per day, 1-2 drops in each eye while wearing contact lenses.

Other names: Refresh Contacts®

Primary outcomes

Best Corrected Visual Acuity

Time frame: Change from Baseline at Day 90

Percentage of Subjects Tabulated by Changes in Line Number at Day 90 from Baseline; Visual Acuity measured by LogMar reported as Snellen equivalents. Better: an increase of 2 lines or more in at least one eye; No Change: a change less than +/- 2 lines in both eyes; Worse: a decrease of 2 lines or more in at least one eye.

Secondary outcomes

Corneal Staining

Time frame: Day 90

Corneal staining of greater or equal to grade 2 at day 90. Grading scale: 0 = None Present; 1 = Trace Finding; 2 = Mild Finding; 3 = Moderate Finding; 4 = Severe Finding

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Jun 5, 2008
Registry last updated: Jul 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed